|
時間
|
主講人
|
課程名稱
|
|
13:40-15:10
|
新光醫院泌尿科
林宜佳 主任
|
Meta-analysis of efficacy and safety with novel hormonal agent apalutamide and enzalutamide
|
|
14:15~14:40
|
林口長庚泌尿科
虞凱傑 醫師
|
PK Relationship of Exposure to MFS and Health-Related Quality of Life in SPARTAN study
|
|
14:40~15:05
|
輔大醫院放腫科
王裕仁 醫師
|
Radiotherapy to the primary tumor for men with newly-diagnosed metastatic prostate cancer: Survival results from STAMPEDE
|
|
16:20~16:50
|
臺大醫院腫醫部
沈盈君 醫師
|
Docetaxel-based therapy improves clinical relapse-free survival in high-risk localized prostate cancer
|
|
16:50~17:20
|
台中榮總泌尿科
王賢祥 主任
|
Role of Abiraterone Acetate + Prednisolone + ADT in High and Low Risk Metastatic Hormone Naïve Prostate Cancer
|
|
17:20~17:50
|
臺大醫院泌尿部
洪健華 醫師
|
Optimal use of PSMA in Prostate Cancer
|
|
17:50~18:00
|
亞東醫院泌尿科
鍾旭東 主任
|
Panel Discussion
|